We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+11.37%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.6B
AUM Growth
+$138M
Cap. Flow
-$50M
Cap. Flow %
-1.92%
Top 10 Hldgs %
18.96%
Holding
285
New
47
Increased
57
Reduced
131
Closed
37

Sector Composition

Rank Sector Weight
1 Industrials 22.41%
2 Healthcare 17.08%
3 Technology 14.96%
4 Financials 12.44%
5 Consumer Discretionary 12.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
51
Teladoc Health
TDOC
$1.7B
$19.7M 0.76%
566,096
+2,784
+0.5% +$92.5K
CTRE icon
52
CareTrust REIT
CTRE
$10.1B
$19.7M 0.76%
1,172,649
-11,990
-1% -$222K
CADE
53
DELISTED
Cadence Bancorporation
CADE
$18.8M 0.73%
694,839
+538,854
+345% +$13M
MSCC
54
DELISTED
Microsemi Corp
MSCC
$18.8M 0.72%
363,638
-7,440
-2% -$391K
MTW icon
55
Manitowoc
MTW
$468M
$18.4M 0.71%
468,977
+168,046
+56% +$6.5M
ADMS
56
DELISTED
Adamas Pharmaceuticals
ADMS
$18.4M 0.71%
542,897
+14,830
+3% +$414K
AAWW
57
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$18.1M 0.7%
308,987
+203,231
+192% +$12.1M
BOX icon
58
Box
BOX
$4.22B
$18.1M 0.7%
855,610
-10,200
-1% -$215K
AIMT
59
DELISTED
Aimmune Therapeutics
AIMT
$17.7M 0.68%
468,113
-73,922
-14% -$2.39M
CLVS
60
DELISTED
Clovis Oncology, Inc.
CLVS
$17.7M 0.68%
260,069
-73,327
-22% -$5.13M
GWRE icon
61
Guidewire Software
GWRE
$12.5B
$17.4M 0.67%
234,842
-1,860
-0.8% -$144K
IOSP icon
62
Innospec
IOSP
$2.08B
$17M 0.66%
240,896
-4,060
-2% -$271K
DSKE
63
DELISTED
Daseke, Inc. Common Stock
DSKE
$16.7M 0.64%
1,168,230
+407,273
+54% +$5.45M
FRPT icon
64
Freshpet
FRPT
$2.78B
$16.3M 0.63%
862,701
+2,577
+0.3% +$44.8K
RETA
65
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$15.9M 0.61%
561,736
-7,680
-1% -$214K
XOG
66
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$15.4M 0.59%
+1,073,353
New +$16.4M
BLUE
67
DELISTED
bluebird bio
BLUE
$15.2M 0.59%
6,600
-7,567
-53% -$15.4M
MNR
68
DELISTED
Monmouth Real Estate Investment Corp
MNR
$15.2M 0.58%
852,439
+146,680
+21% +$2.54M
DERM
69
DELISTED
Dermira, Inc.
DERM
$14.9M 0.57%
+536,425
New +$14.2M
CLDR
70
DELISTED
Cloudera, Inc.
CLDR
$14.8M 0.57%
898,066
+383,070
+74% +$6.16M
CCOI icon
71
Cogent Communications
CCOI
$549M
$14.5M 0.56%
319,701
-163,661
-34% -$7.8M
GTHX
72
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$14.3M 0.55%
721,438
-6,995
-1% -$150K
QTWO icon
73
Q2 Holdings
QTWO
$3.43B
$13.6M 0.53%
369,898
-2,730
-0.7% -$112K
IMPV
74
DELISTED
Imperva, Inc.
IMPV
$13.6M 0.52%
341,412
-315,593
-48% -$13.2M
CIEN icon
75
Ciena
CIEN
$53B
$13.5M 0.52%
642,874
-164,960
-20% -$3.5M

Similar funds

Emerald Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Emerald Advisers held 285 positions worth $2.6B, up 5.6% from $2.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers's Q4 2017 filing shows 47 new, 57 increased, 131 reduced and 37 closed positions. Its largest new stake was Exact Sciences: 415,170 shares worth $21.8M. The largest sale was Cavium, Inc., an estimated $25.5M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Emerald Advisers's largest Q4 2017 buy was Exact Sciences: 415,170 shares worth $21.8M.
  • Emerald Advisers added most to ATI in Q4 2017, an estimated $14.7M increase.
  • Emerald Advisers's biggest Q4 2017 reduction was Ignyta, Inc., cutting an estimated $24.6M.
  • Emerald Advisers fully exited Cavium, Inc. in Q4 2017, selling an estimated $25.5M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.6B portfolio in Q4 2017.
  • Emerald Advisers opened 47 new positions and closed 37 in Q4 2017.
  • Emerald Advisers's portfolio value rose 5.6% quarter-over-quarter to $2.6B.

Based on Emerald Advisers's 13F filing for Q4 2017, filed 5 Feb 2018.